CME Satellite Symposium

A CME Symposium during the 2026 American Heart Association (AHA) Scientific Sessions in Chicago, Illinois.

Dinner and Registration: 5:30–6:00 PM CT
Symposium: 6:00–7:30 PM CT

AGENDA

6:00 PM            Introduction
                           Paul Ridker, MD, MPH (Chair)

6:10 PM            Inflammation in ASCVD—The Biology, The Biomarker, and the Evidence
                           Paul Ridker, MD, MPH

6:30 PM            Inflammation in ASCVD: The Current Therapeutic Landscape
                           Jean-Claude Tardif, MD

6:45 PM            Inflammation in Cardiovascular-Kidney-Metabolic (CKM) Syndrome
                           Katherine Tuttle, MD

7:00 PM            Panel Discussion/Question and Answer

7:25 PM            Concluding Remarks

EDUCATIONAL OBJECTIVES

■ Describe the role of the IL-1β→IL-6→CRP inflammatory pathway in atherosclerotic plaque progression and rupture, and explain the clinical evidence supporting hsCRP as an independent predictor of recurrent MACE in statin-treated patients with ASCVD
■ Identify patients across cardiology subspecialties with established ASCVD and residual inflammatory risk, and apply a structured hsCRP screening and interpretation framework to clinical decision-making
■ Discuss the mechanism, clinical outcomes evidence, safety profile, and appropriate patient selection for low-dose colchicine as the current standard of evidence-based anti-inflammatory secondary prevention
■ Recognize that inflammation is not only a central mediator in the pathological progression of CKM syndrome but also a pivotal molecular hub that drives coordinated damage across multiple organ systems

TARGET AUDIENCE

This program is intended for cardiovascular clinicians.

ACCREDITATION AND CREDIT DESIGNATION

Voxmedia, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Grant

Voxmedia International gratefully acknowledges the educational grant provided by Novo Nordisk Inc.

CHAIR

Paul M. Ridker, MD, MPH
Eugene Braunwald Professor of Medicine
Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital
Boston, Massachusetts

FACULTY

Jean-Claude Tardif, CM, MD
Professor of Medicine
Université de Montréal
Director
Montreal Heart Institute Research Centre
Montreal, Quebec, Canada

Katherine Tuttle, MD
Executive Director for Research
Providence Inland Northwest Health
Spokane, Washington
Professor of Medicine
University of Washington School of Medicine
Seattle, Washington

This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.